Development course of Beijing Boao Biological Co., Ltd.

By the end of 2007, Boao Bio-total assets reached 587 million yuan, with an R&D of 24,000 square meters. Its production and operation facilities include GMP workshop for clinical diagnostic microarray chips and supporting reagents, clean workshop for micro-processing of silicon-based and plastic-based microfluidic chips, and biochip-related equipment production workshop. It has successively obtained the Pharmaceutical Manufacturing Enterprise License and the Medical Device Manufacturing Enterprise License from SFDA in China. Laboratory accreditation certificate issued by China National Accreditation Committee for Conformity Assessment and ISO 900 1, ISO 13485, ISO 17025 quality management system and qualification certification of foreign service laboratories. Boao Bio-tech owns two overseas independent corporate enterprises (Boao Bio-tech Hong Kong Limited and Boao Bio-tech International Limited), and shares in two domestic and foreign holding companies (Aviva Bio-tech and Shenzhen Micro-core Bio-tech Co., Ltd.) through patented technology and cash investment, with more than 400 employees.

The rapid development of Boao's biology has attracted wide attention from all sides. In 2002, Boao Bio, as the only selected company in Asia, was named "the most potential biotechnology company in the world" by American Fortune magazine. In 2003, Boao Bio ranked first among the "Top Ten Biochip Enterprises in China" selected by New Economic Herald magazine sponsored by the State Council Development Research Center. In 2004, Fortune magazine once again wrote that "Boao Company became the first biotechnology company in China to enter the world level"; In 2005, Boao Bio became one of the eight biotechnology companies in Asia 100 unlisted technology companies selected by American Red Herring magazine. In the same year, Time magazine, an authoritative American magazine, made positive reports on Boao Bio twice in a row, pointing out that Boao Bio is a company with independent research and development capabilities, which can develop and produce innovative and cost-effective products. In 2006, Boao Bio ranked first among the top 50 high-tech and high-growth enterprises in Deloitte China, and was selected as a world-renowned recommended supplier of microarray products and services by British magazine Nature. Its HLA genotyping chip detection system, microarray chip laser focusing scanner (Crystal Core &: reg; LuxScan? 10K) and microarray chip sampling system (die&; regSmartArrayer? 48 and crystal core &; regSmartArrayer? 136) was recognized as a national key new product by the Ministry of Science and Technology. In 2007, Boao Bio-declared "Research and Application Project of Systematic Biochip and Related Instruments and Equipment" won the second prize of National Technological Invention Award. In 2008, the National Biochip Standardization Technical Committee was established with the approval of the standardization authorities in the State Council. Beijing Biochip National Engineering Research Center, as the secretariat unit, is responsible for daily management, and its director, Dr. Jing Cheng, is the director of Standardization Committee.

Relying on its excellent R&D, production, marketing and service team, international leading biochip production and service technology platform and high-standard quality assurance system, Boao Bio will provide our customers and partners with advanced Qualcomm biochip technology services and industrial application overall solutions for the application fields such as "life science research, biological (including food) safety testing, health assessment and clinical diagnosis".

Beijing National Engineering Research Center for Biochips is a national R&D institution with the largest sales scale, the strongest R&D strength and the largest number of applications and patents in the field of biochips in China approved by the National Development and Reform Commission (formerly the National Development Planning Commission). Its predecessor was Tsinghua University Biochip R&D Center. On September 30, 2000, according to the instructions of the National Development and Reform Commission, with Tsinghua University as the main sponsor, Huazhong University of Science and Technology, China Academy of Medical Sciences and Academy of Military Medical Sciences jointly established the Beijing National Engineering Research Center for Biochips, which was officially awarded the license on 2001kloc-0/0.

From September 2000 to June 2003, 5438+ 10, with the strong support of the National Development and Reform Commission and the Beijing Municipal Development and Reform Commission, and under the specific coordination of the Zhongguancun Science Park Management Committee, a rented restaurant at No.2 Tsinghua West Road in Haidian District was renovated to become a temporary laboratory and office space for the central scientific research work. From June 5438 to 10, 2003, the first phase of the center was completed and put into use, with a total construction area of 24,000 square meters, including all kinds of world-class engineering and scientific research laboratories, GMP ultra-clean workshop for microarray chip manufacturing, pilot clean workshop for microfluidic chips, life science instrument production workshop and supporting facilities. The center has first-class scientific research facilities, perfect production conditions, strong scientific research atmosphere and a group of senior researchers who are well-known in the international biochip field, including professors, associate professors 10, returned senior researchers 12 and various researchers 180, of which 40% have master's degree or above, forming an echelon and a well-structured talent team. The center has been recognized as a national life science and technology talent training base, a postdoctoral research center, a major high-tech achievement transformation project in Beijing, an excellent patent pilot unit in Beijing, and an achievement industrialization base of the national high-tech research and development plan.

20 10 on may 6, General Secretary of the Communist Party of China (CPC) Central Committee and president Hu Jintao accompanied Kim Jong il, general secretary of the workers' party of Korea and chairman of the national defense commission, to visit Beijing boao biological co., ltd.